Position in TSHA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,305,204
-$19,126,644 QoQ
Shares Held
17,965,371
-0.6% QoQ
Ownership
6.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.12368077453007.ToString("F0")%
Shared 0.ToString("F0")%
None 0.8763192254699332.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. TSHA ranks #37 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in TSHA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,305,204 | 17,965,371 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $99,431,848 | 18,078,518 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $63,135,859 | 19,307,603 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $38,958,336 | 16,865,082 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $23,416,457 | 16,846,374 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $30,517,829 | 17,640,366 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $15,404,623 | 7,663,993 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $16,749,367 | 7,477,397 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $14,834,713 | 5,168,890 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $383,270 | 216,538 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $543,737 | 172,069 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $86,793 | 131,308 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $70,072 | 87,813 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $53,350 | 23,607 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $48,174 | 24,962 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $266,537 | 71,651 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,145,920 | 175,755 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,658,316 | 142,345 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,329,248 | 125,094 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $765,529 | 36,110 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $466,108 | 22,961 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $831,709 | 31,338 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||